X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Abbott India Fact Sheet, Abbott India Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Abbott India Fact Sheet   (KNOL)

Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.

ABBOTT INDIA Price History

Price Rs 7,300.5
Mkt Cap Rs m 155,136
Vol '000 0.3
P/E X 38.7
P/CF X 37.2
EPS (TTM) Rs 188.8
% ch % 0.3
No. of shares m 21.25
% ch week % 2.1
% ch 1-mth % 5.6
% ch 12-mth % 62.0
52 week H/L Rs 7,828.0/4,035.0
(As on Jul 20, 2018 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ABBOTT INDIA Financials

No. of Mths
Year Ending
15
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
ABBOTT INDIA EQUITY SHARE DATA
High Rs1,7934,1196,0155,1906,110 
Low Rs1,3003,7003,7074,3513,996 
Sales per share (Unadj.) Rs1,080.91,077.31,245.01,365.91,552.2 
Earnings per share (Unadj.) Rs93.4107.7120.1130.2188.8 
Diluted earnings per shareRs93.4107.7120.1130.2188.8 
Cash flow per share (Unadj.) Rs103.7114.8126.9137.9196.4 
Dividends per share (Unadj.) Rs23.0031.0035.0040.0055.00 
Adj. dividends per shareRs23.0031.0035.0040.0055.00 
Dividend yield (eoy) %1.50.80.70.81.1 
Book value per share (Unadj.) Rs370.8477.6562.6652.7796.6 
Adj. book value per shareRs370.8477.6562.6652.7796.6 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.43.63.93.53.3 
Avg P/E ratio x16.636.340.536.626.8 
P/CF ratio (eoy) x14.934.138.334.625.7 
Price / Book Value ratio x4.28.28.67.36.3 
Dividend payout %24.628.829.130.729.1 
Avg Mkt Cap Rs m32,85883,079103,296101,373107,376 
No. of employees `0002.82.93.03.13.3 
Total wages/salary Rs m2,9973,0543,4113,4533,937 
Avg. sales/employee Rs Th8,304.07,985.18,950.19,414.79,929.3 
Avg. wages/employee Rs Th1,083.71,065.21,153.91,119.91,185.1 
Avg. net profit/employee Rs Th717.5798.6863.5897.31,207.7 
ABBOTT INDIA INCOME DATA
Net Sales Rs m22,96922,89326,45629,02632,985 
Other income Rs m4824765065761,170 
Total revenues Rs m23,45123,36926,96229,60234,155 
Gross profit Rs m2,6833,1233,6443,9735,245 
Depreciation Rs m219149144164162 
Interest Rs m15252038 
Profit before tax Rs m2,9463,4443,9804,3656,215 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m9611,1541,4281,5982,203 
Profit after tax Rs m1,9852,2902,5532,7674,012 
Gross profit margin %11.713.613.813.715.9 
Effective tax rate %32.633.535.936.635.4 
Net profit margin %8.610.09.69.512.2 
ABBOTT INDIA BALANCE SHEET DATA
Current assets Rs m9,96512,36214,50618,93022,655 
Current liabilities Rs m30,6123,1713,8236,3166,681 
Net working cap to sales %-89.940.140.443.548.4 
Current ratio x0.33.93.83.03.4 
Inventory Days Days5761516365 
Debtors Days Days1721202229 
Net fixed assets Rs m9951,0001,1131,159835 
Share capital Rs m213213213213213 
"Free" reserves Rs m7,6109,93811,74413,65716,715 
Net worth Rs m7,87910,15011,95613,86916,928 
Long term debt Rs m00000 
Total assets Rs m11,39213,66516,16520,65824,162 
Interest coverage x3,682.9689.7158.9215.0163.7 
Debt to equity ratio x00000 
Sales to assets ratio x2.01.71.61.41.4 
Return on assets %17.416.815.913.516.8 
Return on equity %25.222.621.319.923.7 
Return on capital %37.434.033.531.636.9 
Exports to sales %0.60.50.600 
Imports to sales %15.99.912.600 
Exports (fob) Rs m14112216200 
Imports (cif) Rs m3,6592,2643,32200 
Fx inflow Rs m2402152680369 
Fx outflow Rs m4,0412,7373,92703,807 
Net fx Rs m-3,801-2,523-3,6590-3,438 
ABBOTT INDIA CASH FLOW
From Operations Rs m 1,545 2,148 2,487 3,072 1,527 
From Investments Rs m -1,431 -1,867 -772 -1,554 -2,148 
From Financial Activity Rs m -424 -576 -803 -898 -1,024 
Net Cashflow Rs m -309 -295 912 621 -1,646 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 7.9%
FIIs 0.1%
ADR/GDR 0.0%
Free float 17.1%
Shareholders 18,270
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
E-MAIL investor.relations@abbott.co.in WEB www.abbott.co.in
TELEPHONE (022) 6797 8888 FAX (022) 6797 8727
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   BIOCON LTD  AMAR REMEDIES  TORRENT PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  

Compare ABBOTT INDIA With:   BIOCON LTD  AMAR REMEDIES  TORRENT PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; IT Stocks Lead Gains(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in above the dotted line.

Views on news

ABBOTT INDIA Announces Quarterly Results (4QFY18); Net Profit Up 137.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 137.9% YoY). Sales on the other hand came in at Rs 8 bn (up 10.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - WYETH LTD COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS